Skip to main content

Table 1 Selected demographic, behavioural and clinical characteristics of the final sample of HZ patients.

From: Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy

Variables

Overall sample

(n = 441)

PHN one-month definition

(n = 226)

No PHN one-month definition

(n = 210)

P*

PHN

three-month definition

(n = 130)

No PHN

three-month definition

(n = 304)

P*

Demographic characteristics

       

Mean age in years (SD)

58.1 (20.4)

61.1 (18.8)

54.9 (21.7)

0.002

60.4(19.3)

57.0 (21.0)

0.12

 

%

%

%

 

%

%

 

Female gender

56.5

57.5

55.4

0.6

60.0

54.7

0.3

Married

76.4

79.6

73.2

0.10

83.1

73.3

0.02

Higher educational level

39.7

38.9

40.5

0.7

39.2

40.1

0.9

Anamnesis

       

Hypertension

36.0

39.4

32.6

0.14

33.8

36.8

0.7

Diabetes mellitus (missing = 3)

9.1

10.7

7.5

0.2

8.6

9.1

0.9

HCV infection

1.4

2.2

0.5

0.11

1.5

1.3

0.8

HIV infection

1.1

1.8

0.5

0.2

1.5

1.0

0.6

Neoplasm (m = 8)

11.3

12.7

9.9

0.3

10.0

11.4

0.9

Neurological disorders

2.5

3.5

1.4

0.15

3.1

2.3

0.6

Psychiatric illnesses (m = 17)

1.4

1.4

1.5

0.9

0.0

2.1

0.10

Allergy

10.9

15.5

6.1

0.001

16.1

8.8

0.025

Trauma (m = 3)

16.0

24.5

7.0

< 0.001

31.8

9.5

< 0.001

Surgical intervention (m = 3)

31.0

41.5

20.1

< 0.001

46.9

24.5

< 0.001

Alcohol abuse (m = 7)

6.9

4.5

9.5

0.04

4.0

7.9

0.14

Current or former smoking (m = 2)

26.0

32.4

19.2

0.002

38.0

20.9

< 0.001

Familial CHD risk (m = 2)

25.1

29.9

20.0

0.017

31.2

22.2

0.045

Clinical characteristics

       

HZ dermatomeric district

       

Thoracic

49.8

49.1

50.5

0.8

46.9

51.3

0.4

Lumbar

22.9

23.4

22.4

0.8

25.4

21.2

0.3

Cranial

18.2

20.8

15.4

0.14

19.2

18.0

0.8

Cervical

9.1

6.6

11.7

0.07

8.5

9.5

0.7

Pain intensity

       

Mild

40.5

30.1

51.6

< 0.001

26.1

46.9

< 0.001

Moderate

34.2

33.6

34.7

0.8

31.5

35.4

0.4

Intense

18.9

26.1

11.3

< 0.001

30.0

13.8

< 0.001

Very intense

6.4

10.2

2.3

< 0.001

12.3

3.9

0.001

> 50 vesicles (m = 163)

30.2

37.1

22.0

0.007

38.4

26.8

0.054

Missed prescription of antivirals

7.9

11.9

3.7

0.001

16.1

4.6

< 0.001

Use of analgesics in the acute phase

43.0

47.3

38.5

0.061

42.3

43.6

0.8

  1. When no missing observations (m) are indicated, there were no missing values. * Chi-square test for categorical variables; t-test for continuous variables. Only the variables reported in the table have been included in the model.